Human Gene MIR193B (ENST00000384907.1) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
DM175399 - A nucleics Acid regulating cell growth. FZ435759 - JP 2011501949-A/76: DIAGNOSIS AND PROGNOSIS OF SPECIFIC CANCERS. HH826050 - Sequence 3 from Patent WO2010100328. HI979106 - Sequence 33 from Patent EP2234483. HV342488 - JP 2011510623-A/33: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY. HW101991 - JP 2013500034-A/118: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW505268 - JP 2014502606-A/170: MELANOMA TREATMENTS. HZ043354 - JP 2015510401-A/444: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ081980 - JP 2015514392-A/444: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408324 - JP 2015528002-A/921: CHIRAL CONTROL. LF404451 - JP 2015509366-A/444: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LG051658 - KR 1020150036642-A/924: CHIRAL CONTROL. LZ215740 - JP 2017518753-A/91: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS. MA353982 - JP 2018075017-A/444: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MP045622 - Sequence 444 from Patent EP3401394. MP084292 - Sequence 444 from Patent EP3401393. FV524033 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker. FW364088 - Oligonucleotides for modulating target RNA activity. FW393822 - Diagnosis and therapeutic choice of gynecologic cancer using micro RNA as biomarker. HI560974 - Sequence 189 from Patent EP2190992. HI965340 - Sequence 625 from Patent WO2010139812. HI966522 - Sequence 842 from Patent WO2010139811. HI967388 - Sequence 842 from Patent WO2010139810. HI979081 - Sequence 8 from Patent EP2234483. HV342463 - JP 2011510623-A/8: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY. HV555488 - JP 2012016294-A/4: Composition or kit for determining sensitivity to auxiliary chemotherapy of stomach cancer. HV594075 - JP 2010538653-A/189: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV594993 - JP 2010539959-A/374: Micromirs. HW044131 - WO 2012161124-A/4: A composition comprising a miRNA or an expression system of said miRNA. HW101939 - JP 2013500034-A/66: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW413587 - WO 2014003053-A/36: Method for screening pancreatic cancer and test kit therefor. HW505595 - JP 2014502606-A/497: MELANOMA TREATMENTS. HW914652 - JP 2015504847-A/6: TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER. HZ074309 - JP 2013535982-A/400: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ083203 - JP 2015513906-A/560: Stem Cell Microparticles. HZ157550 - JP 2015130862-A/374: Micromirs. HZ186401 - JP 2015146814-A/150: Oligonucleotides for modulating target RNA activity. HZ436984 - JP 2015529450-A/560: Stem Cell Microparticles. HZ479900 - JP 2015535430-A/406: TERMINALLY MODIFIED RNA. HZ789831 - JP 2016504050-A/1576: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287384 - Sequence 66 from Patent WO2011015720. JA401378 - Sequence 625 from Patent WO2011080318. JA402356 - Sequence 625 from Patent WO2011080315. JA403363 - Sequence 625 from Patent WO2011080316. JA405994 - Sequence 625 from Patent EP2336353. JA426731 - Sequence 64 from Patent WO2011072177. JA429520 - Sequence 625 from Patent WO2011095623. JA791631 - Sequence 33 from Patent WO2012089772. JB022272 - Sequence 114 from Patent WO2013026685. JB022854 - Sequence 108 from Patent WO2013026684. JB620485 - Sequence 465 from Patent WO2013063544. JB624369 - Sequence 189 from Patent EP2610342. JB835815 - Sequence 105 from Patent WO2013057567. JC172188 - Sequence 560 from Patent WO2013150303. JC244516 - Sequence 136 from Patent WO2012020308. JC512563 - Sequence 2816 from Patent WO2014113089. JC572999 - Sequence 560 from Patent WO2014125276. JC582687 - Sequence 560 from Patent WO2014125277. JE954383 - Sequence 560 from Patent WO2015052526. JE956136 - Sequence 560 from Patent WO2015052527. JE988588 - Sequence 37 from Patent WO2015121417. LF137888 - JP 2016507550-A/560: Method of Producing Microparticles. LF161285 - JP 2016513950-A/1351: Oligomers with improved off-target profile. LF162853 - JP 2016513095-A/560: Stem Cell Microparticles and miRNA. LF644417 - JP 2016144439-A/8: Method for assessing cell aging. LF953605 - JP 2016534103-A/560: Stem Cell Microparticles and miRNA. LG005950 - KR 1020150004822-A/560: STEM CELL MICROPARTICLES. LG053646 - KR 1020150059168-A/560: STEM CELL MICROPARTICLES. LG240885 - KR 1020160035087-A/560: STEM CELL MICROPARTICLES AND MIRNA. LP714643 - Sequence 15 from Patent WO2015092707. LP727148 - Sequence 842 from Patent EP2883966. LP819418 - Sequence 842 from Patent EP3296406. LP939360 - Sequence 842 from Patent EP3184651. LQ070151 - Sequence 475 from Patent EP2964234. LQ724415 - Sequence 48 from Patent WO2018096084. LQ955611 - Sequence 6 from Patent EP2785355. LV470970 - JP 2016534036-A/560: Stem Cell Microparticles and miRNA. LY405058 - KR 1020160117535-A/363: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ233758 - JP 2017184756-A/150: Oligonucleotides for modulating target RNA activity. MA260297 - JP 2017505623-A/363: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA406037 - WO 2018155427-A/811: A probe with reduced false positive binding, a method to desing the probe, and the use thereof. MA643652 - JP 2017113010-A/1576: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731536 - JP 2017140048-A/406: TERMINALLY MODIFIED RNA. MS673305 - Sequence 108 from Patent EP3135774. MS833484 - Sequence 189 from Patent EP3112464. MS834479 - Sequence 625 from Patent EP3112479. MS901641 - Sequence 114 from Patent EP3156505. MS930522 - Sequence 15 from Patent EP3178943. EF100863 - Homo sapiens microRNA miR-193c, complete sequence. FZ421171 - JP 2010539978-A/71: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. HW502485 - JP 2014050389-A/71: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. AY882278 - Homo sapiens microRNA HSA-MIR-RG-49, complete sequence. FW364087 - Oligonucleotides for modulating target RNA activity. FW371751 - Human-derived nuclear acids for inhibiting HIV protein expression. FZ435744 - JP 2011501949-A/61: DIAGNOSIS AND PROGNOSIS OF SPECIFIC CANCERS. HH826073 - Sequence 26 from Patent WO2010100328. HI560973 - Sequence 188 from Patent EP2190992. HI965341 - Sequence 626 from Patent WO2010139812. HI965850 - Sequence 170 from Patent WO2010139811. HI966716 - Sequence 170 from Patent WO2010139810. HV335769 - JP 2011093892-A/12: Tumor proliferation suppressor comprising tumor suppressive micro RNA. HV543912 - JP 2011217617-A/23: Method for testing fibrosis of chronic liver diseases using miRNAs. HV593860 - JP 2010538610-A/73: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. HV594074 - JP 2010538653-A/188: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV594992 - JP 2010539959-A/373: Micromirs. HW101887 - JP 2013500034-A/14: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells. HW151472 - WO 2013047815-A/17: ENDOPLASMIC RETICULUM STRESS MODULATOR. HW505457 - JP 2014502606-A/359: MELANOMA TREATMENTS. HW608535 - JP 2014515024-A/24: Micro-RNA Inhibitors and Their Uses in Disease. HW669785 - JP 2013537538-A/516: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. HW823970 - JP 2015502176-A/31: Methods and Kits for Detecting Subjects at Risk of Having Cancer. HW913252 - JP 2015504307-A/12: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS. HW914651 - JP 2015504847-A/5: TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER. HZ043319 - JP 2015510401-A/409: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ043375 - JP 2015510401-A/465: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ074310 - JP 2013535982-A/401: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081945 - JP 2015514392-A/409: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ082001 - JP 2015514392-A/465: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ082791 - JP 2015513906-A/148: Stem Cell Microparticles. HZ157549 - JP 2015130862-A/373: Micromirs. HZ186400 - JP 2015146814-A/149: Oligonucleotides for modulating target RNA activity. HZ436572 - JP 2015529450-A/148: Stem Cell Microparticles. HZ479899 - JP 2015535430-A/405: TERMINALLY MODIFIED RNA. HZ789830 - JP 2016504050-A/1575: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA287332 - Sequence 14 from Patent WO2011015720. JA401379 - Sequence 626 from Patent WO2011080318. JA402357 - Sequence 626 from Patent WO2011080315. JA403364 - Sequence 626 from Patent WO2011080316. JA405995 - Sequence 626 from Patent EP2336353. JA426889 - Sequence 222 from Patent WO2011072177. JA429521 - Sequence 626 from Patent WO2011095623. JA660813 - Sequence 267 from Patent WO2011131354. JA682675 - Sequence 143 from Patent WO2011149354. JB158036 - Sequence 24 from Patent WO2012142313. JB620486 - Sequence 466 from Patent WO2013063544. JB624368 - Sequence 188 from Patent EP2610342. JB778633 - Sequence 12 from Patent WO2013078283. JC037650 - Sequence 178 from Patent EP2643479. JC171776 - Sequence 148 from Patent WO2013150303. JC244517 - Sequence 137 from Patent WO2012020308. JC244861 - Sequence 489 from Patent WO2012020308. JC244947 - Sequence 575 from Patent WO2012020308. JC270125 - Sequence 516 from Patent WO2012020307. JC512562 - Sequence 2815 from Patent WO2014113089. JC572587 - Sequence 148 from Patent WO2014125276. JC582275 - Sequence 148 from Patent WO2014125277. JE953971 - Sequence 148 from Patent WO2015052526. JE955724 - Sequence 148 from Patent WO2015052527. JE978822 - Sequence 267 from Patent EP2865765. LF137476 - JP 2016507550-A/148: Method of Producing Microparticles. LF161162 - JP 2016513950-A/1228: Oligomers with improved off-target profile. LF162441 - JP 2016513095-A/148: Stem Cell Microparticles and miRNA. LF404416 - JP 2015509366-A/409: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF636285 - JP 2016519076-A/59: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LF857624 - JP 2015130879-A/73: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. LF953193 - JP 2016534103-A/148: Stem Cell Microparticles and miRNA. LG005538 - KR 1020150004822-A/148: STEM CELL MICROPARTICLES. LG053234 - KR 1020150059168-A/148: STEM CELL MICROPARTICLES. LG134442 - KR 1020150131312-A/59: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LG240473 - KR 1020160035087-A/148: STEM CELL MICROPARTICLES AND MIRNA. LP726476 - Sequence 170 from Patent EP2883966. LP818746 - Sequence 170 from Patent EP3296406. LP938688 - Sequence 170 from Patent EP3184651. LQ070150 - Sequence 474 from Patent EP2964234. LQ244871 - Sequence 10 from Patent WO2016040242. LQ245135 - Sequence 10 from Patent WO2016040246. LQ500659 - Sequence 73 from Patent EP3048177. LQ955610 - Sequence 5 from Patent EP2785355. LQ955742 - Sequence 73 from Patent EP2775001. LQ970621 - Sequence 31 from Patent EP2800820. LV470558 - JP 2016534036-A/148: Stem Cell Microparticles and miRNA. LV539175 - JP 2016539127-A/176: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE. LX270582 - JP 2016056210-A/516: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. LY298577 - KR 1020160079824-A/176: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE. LY405057 - KR 1020160117535-A/362: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY416912 - KR 1020160145093-A/18: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY. LY504791 - KR 1020170035932-A/180: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. LZ215693 - JP 2017518753-A/44: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS. LZ233757 - JP 2017184756-A/149: Oligonucleotides for modulating target RNA activity. LZ243072 - JP 2017525350-A/180: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. LZ993005 - JP 2017532547-A/9: METHODS FOR INHIBITING HMGB1 ACTIVATION OF MELANOCYTES, METHOD FOR IDENTIFICATION OF AGENTS SUITABLE FOR SUCH INHIBITON. MA260296 - JP 2017505623-A/362: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA353947 - JP 2018075017-A/409: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MA405734 - WO 2018155427-A/508: A probe with reduced false positive binding, a method to desing the probe, and the use thereof. MA419978 - JP 2018518169-A/29: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420056 - JP 2018518169-A/107: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420088 - JP 2018518169-A/139: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420105 - JP 2018518169-A/156: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420130 - JP 2018518169-A/181: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420164 - JP 2018518169-A/215: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420186 - JP 2018518169-A/237: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA643651 - JP 2017113010-A/1575: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA730729 - JP 2017125065-A/516: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. MA731535 - JP 2017140048-A/405: TERMINALLY MODIFIED RNA. MP045587 - Sequence 409 from Patent EP3401394. MP075739 - Sequence 78 from Patent WO2019002265. MP084257 - Sequence 409 from Patent EP3401393. MP084313 - Sequence 465 from Patent EP3401393. MS833483 - Sequence 188 from Patent EP3112464. MS834480 - Sequence 626 from Patent EP3112479. MS837410 - Sequence 5 from Patent EP3121289. MS904157 - Sequence 73 from Patent EP3138926. MS944924 - Sequence 180 from Patent EP3177739. CS548324 - Sequence 1354 from Patent EP1777301. DM174454 - A nucleics Acid regulating cell growth. FW312066 - DETECTING NUCLEIC ACIDS. HV534422 - WO 2011111715-A/938: Nucleic acid for controlling cell cycle. JC334388 - Sequence 306 from Patent EP2487240. LP636962 - Sequence 12 from Patent EP2848702. MA800705 - JP 2018183181-A/1576: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA800704 - JP 2018183181-A/1575: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129660 - Sequence 560 from Patent EP3470073. MP133786 - Sequence 3 from Patent WO2019038456. MP162583 - Sequence 560 from Patent WO2019069093. MP129248 - Sequence 148 from Patent EP3470073. MP133787 - Sequence 4 from Patent WO2019038456. MP162171 - Sequence 148 from Patent WO2019069093. MP168034 - Sequence 41 from Patent EP3469101. MA886370 - WO 2019049612-A/10: An antitumor agent, food and beverage for prevention of cancer and an agent for increasing expression of tumor-suppressive microRNA. MA989570 - JP 2017530116-A/9: METHOD OF MAKING A SKIN CARE COMPOSITION. MP280603 - Sequence 23 from Patent WO2019111197. MP283516 - Sequence 23 from Patent WO2019111198. MB407045 - WO 2019159884-A/535: Kit, device, and method for detection of dementia. MB407445 - WO 2019159884-A/935: Kit, device, and method for detection of dementia. MB406646 - WO 2019159884-A/136: Kit, device, and method for detection of dementia. MB420640 - JP 2019154320-A/8: Method for evaluating cell quality. MB481461 - JP 2019528758-A/41: Methods And Compositions For Prostate Cancer Diagnosis And Treatment. MP325463 - Sequence 10 from Patent EP3536789. MP335219 - Sequence 1 from Patent WO2019185823. MP337292 - Sequence 1 from Patent EP3546597.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: NR_030177, uc021tdg.1 UCSC ID: ENST00000384907.1 RefSeq Accession: NR_030177
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|